Eli Lilly Logo

Tirzepatide Once Weekly for the Treatment of Obesity

FDA approves subcutaneous tirzepatide injection (Mounjaroâ„¢) for Type 2 Diabetes

New Ozempic Dose Approved by FDA

Patoulias D et al.

Hao Z et al.

Kadowaki T et al.

Effects of empagliflozin on markers of liver steatosis and fibrosis and their relationship to cardiorenal outcomes